98 related articles for article (PubMed ID: 24655969)
1. Usefulness of follow-up biopsies at one year after ABO-incompatible kidney transplantation.
Koshino K; Ushigome H; Nakao T; Harada S; Sakai K; Suzuki T; Nobori S; Ito T; Yoshimura N
Transplant Proc; 2014; 46(2):385-7. PubMed ID: 24655969
[TBL] [Abstract][Full Text] [Related]
2. The excellent outcomes of ABO-incompatible kidney transplantation with high titer (>×2048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports.
Koshino K; Okamoto M; Sakai K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Okajima H; Yoshimura N
Transplant Proc; 2011; 43(6):2379-82. PubMed ID: 21839272
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M
Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
[TBL] [Abstract][Full Text] [Related]
4. Japan's experience with living-donor kidney transplantation across ABO barriers.
Ichimaru N; Takahara S
Nat Clin Pract Nephrol; 2008 Dec; 4(12):682-92. PubMed ID: 18941430
[TBL] [Abstract][Full Text] [Related]
5. Kidney transplantation of living unrelated donor-recipient combinations.
Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Kimura T; Nukui A; Yashi M
Transplant Proc; 2012 Jan; 44(1):254-6. PubMed ID: 22310625
[TBL] [Abstract][Full Text] [Related]
6. Kidney transplantation of living unrelated and ABO-incompatible donor-recipient combinations.
Ishikawa N; Yagisawa T; Kimura T; Sakuma Y; Fujiwara T; Nukui A; Yashi M
Transplant Proc; 2013 Apr; 45(3):1242-4. PubMed ID: 23622668
[TBL] [Abstract][Full Text] [Related]
7. Usefulness and safety of high-dose mizoribine on ABO-incompatible living related kidney transplantation using anti-CD20 and anti-CD25 antibodies without splenectomy: 3-year results.
Yoshimura N; Ushigome H; Nobori S; Suzuki T; Sakai K; Koshino K; Nakamura T; Nakao T; Harada S; Ito T
Transplant Proc; 2014; 46(2):391-4. PubMed ID: 24655971
[TBL] [Abstract][Full Text] [Related]
8. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N
Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
[TBL] [Abstract][Full Text] [Related]
10. Impact of positive PRA on the results of ABO-incompatible kidney transplantation.
Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Toma H
Transplant Proc; 2004 Sep; 36(7):2169-71. PubMed ID: 15518789
[TBL] [Abstract][Full Text] [Related]
11. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
Gloor JM; Lager DJ; Moore SB; Pineda AA; Fidler ME; Larson TS; Grande JP; Schwab TR; Griffin MD; Prieto M; Nyberg SL; Velosa JA; Textor SC; Platt JL; Stegall MD
Transplantation; 2003 Apr; 75(7):971-7. PubMed ID: 12698082
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
[TBL] [Abstract][Full Text] [Related]
13. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
[TBL] [Abstract][Full Text] [Related]
14. Japanese experience of ABO-incompatible living kidney transplantation.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S4-7. PubMed ID: 18162988
[TBL] [Abstract][Full Text] [Related]
15. ABO incompatible living donor kidney transplantation in Korea: highly uniform protocols and good medium-term outcome.
Kong JM; Ahn J; Park JB; Chung BH; Yang J; Kim JK; Huh KH; Kim JM
Clin Transplant; 2013; 27(6):875-81. PubMed ID: 24118271
[TBL] [Abstract][Full Text] [Related]
16. Present status of ABO-incompatible kidney transplantation in Japan.
Takahashi K; Saito K
Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
[TBL] [Abstract][Full Text] [Related]
17. Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan.
Takahashi K; Takahara S; Uchida K; Yoshimura N; Toma H; Oshima S; Sonoda T;
Transplant Proc; 2005 May; 37(4):1800-3. PubMed ID: 15919471
[TBL] [Abstract][Full Text] [Related]
18. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
19. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
[TBL] [Abstract][Full Text] [Related]
20. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
